What is the Interpretation between the two companies' ratios for The 2015 & 2016 Celgene & 2015 & 2016 Gilead Financial statements used to calculate these ratios.

		Gilead Sciences Inc.			Celgene Corp.
Earnings per Share of Common Stock (basic - common)	As given in the income statement			$ 10.08			$ 2.57
Current Ratio	Current Assets	$20,445.0	=	2.22	$10,867.5	=	3.67
	Current Liabilities	$9,219.0			$2,959.2
Gross (Profit) Margin Percentage	Gross Margin	$26,129.0	=	86.0%	$10,746.6	=	96.1%
	Net Sales	$30,390.0			$11,184.6
Rate of Return (Net Profit Margin) on Sales	Net Income	$13,488.0	=	44.4%	$1,999.2	=	17.9%
	Net Sales	$30,390.0			$11,184.6
Inventory Turnover	Cost of Goods Sold	$4,261.0		2.4	$438.0		0.9
	Average Inventory	$1,771.0		times	$470.7		times
Days' Inventory Outstanding (DIO)	365 Days	$365.0	=	152	$365.0	=	392
	Inventory Turnover	$2.4		days	$0.9		days
			=